Upload
nawaf-alsham
View
220
Download
0
Embed Size (px)
Citation preview
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 1/23
Evolving Strategies for HyponatremiaManagement in the ICU
Mazen Kherallah, MD, FCCPInfectious Disease & Critical Care Medicine
Assistant Professor, University of orth Da!ota
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 2/23
Criti"al Care Patients at In"rease#$is! of Hyponatremia%
Increased age1
Up to 30% of patients with subarachnoid hemorrhage2
Up to 30% of ICU patients3
!er 30% of "ID# patients$
ostoperati!e patients
2'%(3'% of pituitar) surger) for tumor resection'
*30% of acute spinal cord in+ur),
s)chiatric inpatients- ,%(1.%.
%Data not e&"l'sive to patients (ith e'volemi" hyponatremia)1/ awins C/ Clin Chim Acta/ 200333.-1,4(1.2 2/ Ma)er #"/ The Neurologist / 144'1-.1(5'3/ De6ita M6 et al/ Clin Nephrol/ 14403$-1,3(1,, $/ 7ang 88 et al/ Am J Med/ 14434$-1,4(1.$'/ 9hardwa+ "/ Ann Neurol/ 200,'4-224(23, ,/ eru::i 87 et al/ Crit Care Med/ 144$22-2'2(2'5./ #iegler ;< et al/ Arch Intern Med/ 144'1''-4'3(4'./
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 3/23
Mortality $elate# to HyponatremiaAmong Hospitalize# Patients
"nderson1 7er:ian2 7ierne)30%
'%
10%
1'%
20%
2'%
=>a?@ A130 m;B< >ormonatremia
1/ "nderson et al/ An Intern Med. 144'E102- 1,$(1,52/ 7er:ian C et al/ J Gen Intern Md. 144$E4-54(413/ 7ierne) 8M et al/ J Gen Intern Med. 145,1- 350(35'
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 4/23
Mor*i#ities in Hospitalize# Patients (ithSymptomati" Hyponatremia
0%
10%
20%
30%
$0%
'0%
,0%
• #ingle centerE retrospecti!e o!er $ )ears F144.(2001G• 1,5 patients with serum =>a?@ A11' m;B<• #)mptoms of h)ponatremic encephalopath) in 54 of 1,5 patient F'3%G• >o documented s)mptoms in .4 of 1,5 patients F$.%G
>:enue CM et al/ >atl Med "ssoc/ 20034'- 33'(3$3
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 5/23
Me"hanisms of Hyponatremia
H=>a?@
H=>a?@
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 6/23
9rain C7 #can- Cerebral ;dema
ormal C+ S"anFatal
Hyponatremia
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 7/23
Case I
44 year old man with schizophrenia is brought to the ED from his group home after
a witnessed tonic-clonic generalized seizure.
He was well until earlier in the day at which time he became progressively
somnolent.
His medications include haloperidol, quetiapine and citalopram.
n e!am he is afebrile, "# $%&'(), H* +%. He is somnolent but arousable and
following commands, is euvolemic, and there are no focal findings.
His urine output is $%& ml'hour
Ser'm Urine
>a 11, m;B< >a 3' m;B<
K 3/4 m;B< K 1' m;B<
Creat 0/5 mgd< sm 42 msmg
sm 2$0 msmg
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 8/23
'estion
hat is the most liely etiology of this mans
hyponatremia/
a0 1yndrome of inappropriate antidiuresis b0 #sychogenic polydipsia
c0 #seudohyponatremia
d0 2drenal insufficiency
e0 3erebral sat wasting
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 9/23
+he Diagnosis of Hyponatremia-Three Critical Questions
Is it real.Is (ater
e&"retionappropriate.
Is ADHe&"retion
/appropriate0.
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 10/23
Assessment of Hyponatremia-Three Critical Questions
Hypovolemia Appropriate ADH Secretion
EuvolemiaInappropriate ADH
HypervolemiaMaladaptive ADH Secretion
Total body water ↓Total body Na+ ↓↓
Total body water ↑Total body Na+ ↔
Total body water ↑↑Total body Na+↑
U[Na+ !"# $%&'( U[Na+ )"# $%&'( U[Na+ !"# $%&'( U[Na+ !"# $%&'( U[Na+ "# )$%&'(
Renal LossesDi*retic ece,,Mineralocorticoidde-iciency.icarbonat*ria wit/t*bal acido,i, and$etabolic al0alo,i,
1eton*ria2,$otic di*re,i,
Extrarenal losses3o$itin4Diarr/eaT/ird ,pacin4 o--l*id,.*rn,5ancreatiti,
Tra*$a
6l*cocorticoid de-iciencyHypot/yroidi,$Syndro$e o-inappropriate ADH,ecretion
Ac*te or c/ronicrenal -ail*re
Nep/rotic ,yndro$e7irr/o,i,7ardiac -ail*re
1. Is it real? 5la,$a 2,$olality Normal or High5,e*do/yponatre$iaHyper4lyce$ia A8ote$ia9 %T2H Intoication
Low
2. Is water excretion appropriate? Urine 2,$olalityLow
:) ;## $2,$'04<5,yc/o4enic polydip,ia
High:!;## $2,$'04<
3. Is !H secretion appropriate? "3ol*$e Stat*,#
123m4sm5!g
61m4sm5!g
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 11/23
Case II
4-year-old woman admitted to
5eurocritical 3are 6nit confused and
mildly lethargic secondary to subarachnoid
hemorrhage
#ast medical history7 hypertension, tobaccosmoer
"# $(&'() mm Hg, H* ($ bpm
&.+8 saline administered at $&& m9'h
3:# -) mm Hg
;ildly positive fluid balance *emained confused and disoriented, but
lethargy gradually resolved
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 12/23
In the Step7Do(n Unit
Day + post-12H
#atient transferred to step-down unit
3entral venous <: catheter discontinued
<: fluid7 normal saline administered at $&& m9'h through peripheral <:
Day $& post-12H
=he patient appeared to be more confused
1erum >5a?@ A $% mEq'9
Ser'm Urine
>a 12, m;B< >a $' m;B<
K 3/, m;B< K 1. m;B<
Creat 0/. mgd< sm 242 msmg
sm 2'5 msmg
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 13/23
'estion
hat is the most liely etiology of this patients
hyponatremia/
a0 1<2DH b0 #sychogenic polydipsia
c0 #seudohyponatremia
d0 2drenal insufficiency
e0 3erebral sat wasting
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 14/23
Assessment of Hyponatremia-Three Critical Questions
Hypovolemia Appropriate ADH Secretion
EuvolemiaInappropriate ADH
HypervolemiaMaladaptive ADH Secretion
Total body water ↓Total body Na+ ↓↓
Total body water ↑Total body Na+ ↔
Total body water ↑↑Total body Na+↑
U[Na+ !"# $%&'( U[Na+ )"# $%&'( U[Na+ !"# $%&'( U[Na+ !"# $%&'( U[Na+ "# )$%&'(
Renal LossesDi*retic ece,,Mineralocorticoidde-iciency.icarbonat*ria wit/t*bal acido,i, and$etabolic al0alo,i,
1eton*ria2,$otic di*re,i,
Extrarenal losses3o$itin4Diarr/eaT/ird ,pacin4 o--l*id,.*rn,5ancreatiti,
Tra*$a
6l*cocorticoid de-iciencyHypot/yroidi,$Syndro$e o-inappropriate ADH,ecretion
Ac*te or c/ronicrenal -ail*re
Nep/rotic ,yndro$e7irr/o,i,7ardiac -ail*re
1. Is it real? 5la,$a 2,$olality Normal or High5,e*do/yponatre$iaHyper4lyce$ia A8ote$ia9 %T2H Intoication
Low
2. Is water excretion appropriate? Urine 2,$olalityLow
:) ;## $2,$'04<5,yc/o4enic polydip,ia
High:!;## $2,$'04<
3. Is !H secretion appropriate? "3ol*$e Stat*,#
189m4sm5!g
161m4sm5!g
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 15/23
'estion
ow would )ou treat this patientL
aG luid restriction FA2 <dG
bG #alt tablets F>aCl 2 gdGcG >ormal saline infusion
dG 3% h)pertonic saline
eG I6 Coni!aptan
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 16/23
+reatment Consi#erations
• ften unnown• N2 da)s• "cute reduction
in chronic state• More brain
adaptation withchronic
A"'te orChroni"
• Mild- N124• Moderate-
121(124• #e!ere A120
Severity ofHyponatremia
• #e!ere #)mptoms
or Intracranialatholog)- sei:uresEimpaired mentalstatus or coma
• Moderate-confusionE letharg)E
• Mild- fatigueEnauseaE di::inessEgait disturbancesEforgetfulness nd
muscle cramps• "s)mptomatic
Severity ofSymptoms
• 7reat cerebraledema
• elie!e s)mptomsand pre!entprogression of
neurologicd)sfunction• re!ent osmotic
dem)elinations)ndrome
• $(, meB2$ hrsFA4 meB< in an)2$ hrsG
+reatment:oals
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 17/23
+reatment Strategies
• 7reat painEnauseaE!omitingE//
• cessation oftherap) withcertain drugs
• glucocorticoidsto patients withadrenal
insuOcienc)
+reatUn#erlying
Ca'se
• #aline to patientswith true !olumedepletion
• Diuretics inedematous statesFsuch as heart
failure andcirrhosisG
$estoration of
E'volemia
• luid restrictionin #I"D
;alan"ing theE<e"t of ADH
• )pertonicsaline
• >ormal saline• #alt tablets
Corre"tion ofa an# $ate of
Corre"tion
So#i'm #e="it> +;? @#esire# Sa7a"t'al Sa
In"rease in Sa> @inf'sate Ba7Sa @+;?
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 18/23
+reatment 4ptions
• F># in h)po!olemiaG• luid restriction FAU or A500
mlda)G• #alt tablets• 62 receptors antagonists
• F># in h)po!olemiaG• )pertonic saline• Increase >a 0/'(1 meBhour in the
Prst $ hours• $(, meB in 2$ hours
•
• )pertonic saline• Increase >a 0/'(1 meBhour in
the Prst $ hours• $(, meB in 2$ hours FA4 meBin
an) 2$ hoursG
• apid increase in >a $(, meB<Fin , hoursG
• 3% saline 100 m< I6 bolus• epeat 1(2 Q at 10 minutes
inter!als if s)mptoms persist• R 4 meB< in 2$ hours
SevereSymptoms- Seiz'reor "oma
Mo#erate
Symptoms-Conf'sion
an#5orlethargy
Mil# ora*s"ent
symptoms- a G
13me5
Mil# ora*s"ent
symptoms- aJ13me5
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 19/23
+reatment Co'rse for +his Patient
" 20 mg loading dose of coni!aptan followed b) acontinuous infusion of 20 mgd
2$ hour after the start of the loading doseE the serum=>a?@ increased from 12, to 132
" second 2$ hour contineous infusion gi!en
SAH
Day
Ser'm Ba
@mE5
12 Ho'r
Fl'i#;alan"e @
Conivaptan
+reatmentDay
10 12, ?0/2 1
11 132 (0/5 2
12 135 (1/2 3
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 20/23
Day 1 of +reatment
7he neSt da) serum =>a?@ increased from 132 to135 m;B<
Mental status- less confused
Coni!aptan discontinued
atient discharged to rehabilitation on #" Da) 13
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 21/23
$e"eptor7Me#iate# E<e"ts of AP
Receptor Subtype Site of Action Activation Effects
:$a :ascular smooth musclecells
#latelets9ymphocytes andmonocytes2drenal corte!
:asoconstriction#latelet aggregation
3oagulation factor releaseBlyconeogenesis
:$b 2nterior pituitary 23=H and C-endorphin
release:% *enal collecting duct
principal cellsree water absorption
<ee C et al/ "M eart / 20031$3-4(15
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 22/23
Hyponatremia in A"'te ;rain InL'ry+herape'ti" 4ptions
Spee# Sit'ation Pl'ses Min'ses
Free (aterrestri"tion
#low ard toregulate
Sf'rosemi#e #ow ;lectrol)tedepletion
Fl'#ro"ortisone
#low luid o!erload
AP Inhi*itor aster "s)mptomatic
h)ponatremia
eliable eTect Infusion sitereactions
Mannitol atsest #)mptomatich)ponatremia
educe;dema
Can worsenh)po!olemia;lectrol)tedepletion
Hypertoni"
saline
astest #)mptomatic
h)ponatremia
educe brain
edema
luid o!erload
7/23/2019 Management of Hyponatremia2
http://slidepdf.com/reader/full/management-of-hyponatremia2 23/23
7han )ou